Form 4: Moderna Director Sandra Horning Acquires Stock Options and Restricted Stock Units
SEC Form 4 Filing
Director Sandra Horning acquired stock options and restricted stock units in Moderna, Inc. on May 6, 2024.
Summary
- On May 6, 2024, Sandra Horning, a director of Moderna, Inc., acquired 5,668 stock options with an exercise price of $122.13.
- These options vest fully on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, contingent upon continued service.
- Horning also acquired 979 restricted stock units (RSUs), which convert to common stock on a one-for-one basis.
- These RSUs will vest fully on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to continued service.
- Following these transactions, Horning directly owns 5,668 stock options and 979 restricted stock units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options and RSUs by a director is generally viewed as a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily imply a significant change in the company's outlook.
Positives
- The acquisition of stock options and RSUs by a director signals confidence in the company's future performance.
- The vesting schedule aligns the director's interests with those of the shareholders, encouraging long-term value creation.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's prospects. Acquisitions of stock by directors are often seen as a positive sign.
Comparison to Industry Standards
- Stock option and RSU grants are common forms of executive compensation in the biotechnology industry, used to align management's interests with shareholder value.
- Companies like Pfizer, BioNTech, and Novavax also utilize similar equity-based compensation plans for their executives and directors.
- The vesting schedules and terms are generally comparable to industry standards, with vesting typically occurring over a period of one to four years.
Stakeholder Impact
- The acquisition of stock options and RSUs by a director can positively influence shareholder sentiment.
- It aligns the director's interests with those of the shareholders, potentially leading to better decision-making and long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 05/06/2024 | Date of transaction: Sandra Horning acquired stock options and restricted stock units. |
| 05/06/2025 | Vesting date for stock options and restricted stock units, or earlier if Moderna's next Annual Meeting of Stockholders occurs before this date, subject to continued service. |
| 05/06/2034 | Expiration date for the acquired stock options. |
| 05/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.